Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: During the quarter ended September 30, 2022, Omega did not issue any shares of Omega common stock in exchange for Omega OP Units.
+Added: From time to time, the Company issues shares of common stock in reliance on the private placement exemption under Section 4(a)(2) of the Securities Act of 1933, as amended, in exchange for Omega OP Units.
+Added: During the quarter ended March 31, 2023, we did not issue any shares of our common stock in exchange for Omega OP Units.
Issuer Purchases of Equity Securities
−Removed: On January 27, 2022, the Board authorized the Company to repurchase of up to $500 million of our outstanding common stock from time to time through March 2025.
+Added: On January 27, 2022, the Board of Directors authorized the Company to repurchase of up to $500 million of our outstanding common stock from time to time through March 2025.
The Company is authorized to repurchase shares of its common stock in open market and privately negotiated transactions or in any other manner as determined by the Company’s management and in accordance with applicable law.
1 unchanged sentence
The Company has no obligation to repurchase any amount of its common stock, and such repurchases, if any, may be discontinued at any time.
−Removed: During the third quarter of 2022, we did not repurchase any shares of our outstanding common stock.
+Added: During the first quarter of 2023, we did not repurchase any shares of our outstanding common stock.
Item 6–Exhibits
−Removed: Amended and Restated Bylaws of Omega Healthcare Investors, Inc.
−Removed: as of October 21, 2022 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed October 21, 2022).
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer of Omega Healthcare Investors, Inc.*
2 unchanged sentences
Section 1350 Certification of the Chief Financial Officer of Omega Healthcare Investors, Inc.*
−Removed: The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL:
−Removed: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Changes in Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
+Added: The following financial statements (unaudited) from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL:
+Added: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101).
2 unchanged sentences
OMEGA HEALTHCARE INVESTORS, INC.
−Removed: November 3, 2022
TAYLOR PICKETT
1 unchanged sentence
Chief Executive Officer
−Removed: November 3, 2022
/S/ ROBERT O.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.